CALL/AMGEN/450/0.1/16.08.24 Share Price

DE000GG4ZF82

Real-time BOERSE MUENCHEN 05:55:24 04/06/2024 pm IST
0.03 ^EUR	-28.57%

Current month	+110.00%
1 month	-42.47%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart AMGEN INC.

Latest news about AMGEN INC.

AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE	04/06	PR
Amgen : 2024 Annual Meeting of Stockholders Presentation	01/06	PU
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment	29/05	RE
Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval	29/05	DJ

More news

Quotes 5-day view

Date	Price	Change
04/24/04	0.03	-28.57%
03/24/03	0.042	+110.00%
31/24/31	0.02	-25.93%
30/24/30	0.027	+28.57%
29/24/29	0.021	-27.59%

Real-time BOERSE MUENCHEN

Last update June 04, 2024 at 05:55 pm IST

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	AMGEN INC.
Issuer	Goldman Sachs
WKN	GG4ZF8
ISIN	DE000GG4ZF82
Date issued	07/03/2024
Strike	450 $
Maturity	16/08/2024 (73 Days)
Parity	10 : 1
Emission price	0.02 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.073 €
Lowest since issue	0.011 €
Spread	0.1 €
Spread %	76.92%

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.

Sector

More about the company

Ratings for Amgen Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Consensus: Amgen Inc.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

307.4 USD

Average target price

316.3 USD

Spread / Average Target

+2.88%

Consensus